Results 221 to 230 of about 77,046 (263)

B-cell non-Hodgkin's lymphoma of the paranasal sinuses

The Journal of Laryngology & Otology, 1994
AbstractPrimary nasal, paranasal, oral and pharyngeal (NPOP) lymphoma, thought to be a distinct entity among childhood lymphomas, may present with a wide variety of common ENT symptoms such as nasal obstruction, rhinorrhoea, epistaxis or sinusitis. The diagnosis may only be recognized when the disease results in symptoms such as visual loss, facial ...
S, Juman, P, Robinson, A, Balkissoon, K, Kelly   +3 more
openaire   +2 more sources

Therapeutic vaccines for non-Hodgkin B-cell lymphoma

Clinical and Translational Oncology, 2008
Despite current therapeutic strategies for B-cell lymphoma, including chemotherapy and transplantation, the majority of patients are not cured. The characterisation of several tumour antigens has made immunotherapy an interesting approach to the treatment of patients with lymphoma.
openaire   +2 more sources

Antibody therapy of non-Hodgkin's B-cell lymphoma

Cancer Immunology, Immunotherapy, 2003
Engineering antibodies with reduced immunogenicity and enhanced effector functions, and selecting antigen targets with the appropriate specificity, density, and/or functionality, have contributed to the recent clinical successes in using unconjugated "naked" antibody therapies of B-cell lymphoma (rituximab) and breast carcinoma (Herceptin).
Paul, Chinn, Gary, Braslawsky, Christine, White, Nabil, Hanna   +3 more
openaire   +2 more sources

Childhood B-Cell Non-Hodgkin's Lymphoma in Israel

Leukemia & Lymphoma, 1994
The non-Hodgkin's lymphomas of childhood and adolescence are a heterogeneous group of diseases that constitute 7-10 percent of all pediatric malignancies. Major strides have been made in recent years in understanding the pathogenesis of lymphomas at a molecular level but have not yet led to a modification of clinical management.
C, Kaplinsky, R, Zaizov
openaire   +2 more sources

AGGRESSIVE NON-HODGKIN'S LYMPHOMA: T-CELL VERSUS B-CELL

Hematological Oncology, 1996
This study is aimed to define the clinical characteristics, treatment of outcome and independent prognostic factors of 144 patients with T- and 357 B-cell non-Hodgkin's lymphomas. Entities with well-defined immunophenotype and clinical characteristics were excluded. Patients with T-cell tumours were younger.
Liang, R, Todd, D, Ho, FCS
openaire   +3 more sources

Editorial Perspective—Advances in B-Cell Non-Hodgkin's Lymphoma

Leukemia & Lymphoma, 2003
Radioimmunotherapy (RIT) represents an exciting new therapeutic option for the treatment of B-cell non-Hodgkin's lymphoma (NHL), emerging at a time when significant advances have been made in NHL classification, molecular genetics and treatment.
Hagenbeek, A., Bischof Delaloye, A.
openaire   +3 more sources

Emerging therapies for B-cell non-Hodgkin lymphoma

Expert Review of Anticancer Therapy, 2009
In recent years considerable progress has been made in the treatment of patients with B-cell non-Hodgkin lymphoma (NHL). Although responses can be achieved with combination chemotherapy regimens, a substantial proportion of patients are still not cured. In recent years, the knowledge of the cellular and molecular biology of distinct types of B-cell NHL
openaire   +2 more sources

Primary non-Hodgkin B-cell lymphoma of the tongue

British Journal of Oral and Maxillofacial Surgery, 2011
A 96-year-old woman was admitted with a mass in the tongue. Examination and imaging (computed tomography and magnetic resonance imaging) showed a mass (2cm×2cm×1.5cm) in the dorsal aspect of the tongue, which was biopsied. Histologically there was diffuse proliferation of large malignant lymphoid cells.
openaire   +2 more sources

Noncoding RNAs in B cell non-Hodgkins lymphoma

Gene
B-cell non-Hodgkins lymphomas (BCNHLs) are a category of B-cell cancers that show heterogeneity. These blood disorders are derived from different levels of B-cell maturity. Among NHL cases, ∼80-90 % are derived from B-cells. Recent studies have demonstrated that noncoding RNAs (ncRNAs) contribute to almost all parts of mechanisms and are essential in ...
Zahra Abedi Kichi, Niloofar Dini, Mahbubeh Rojhannezhad, Zeinab Shirvani Farsani   +3 more
openaire   +2 more sources

Indolent B-cell non-Hodgkin's lymphomas.

Oncology (Williston Park, N.Y.), 1998
The indolent B-cell non-Hodgkin's lymphomas are a diverse group of disorders that differ markedly with respect to presenting features and natural history. This article reviews entities that have generally been encompassed under the category of indolent lymphomas in various classifications, including the Working Formulation, although many were not ...
J E, Seng, B A, Peterson
openaire   +1 more source